Holen Sie sich die Stockscreener-App
1.69
1.74%
-0.03
Handel nachbörslich:
1.61
-0.08
-4.73%
Mainz Biomed N V Aktie (MYNZ) Neueste Nachrichten
Mainz Biomed Wins Swiss Regulatory Approval for Colorectal Cancer Screening Test - MarketScreener
Mainz Biomed’s colorectal cancer test receives Swiss regulatory approval By Investing.com - Investing.com South Africa
Mainz Biomed N.V. Receives Swiss Regulatory Approval to Market ColoAlert - MarketScreener
Is Mainz Biomed N.V. stock reversal real or fakeShort-Term Profit Alert With Entry Forecast - Newser
Mainz Biomed Secures $3 Million Through Securities Purchase Agreement - The Globe and Mail
Mainz Biomed Secures $3 Million in Funding Through Securities Purchase Agreement - AInvest
Mainz Biomed Prices $3 million Follow-on Offering at $1.35 per Unit - MarketScreener
Mainz Biomed raises $3M in follow-on offering. - AInvest
Mainz Biomed Prices $3.0M Follow-On Offering of Over 2.2M Units Including Ordinary Shares and Series A Warrants - 富途牛牛
Mainz Biomed Raises $3M in Follow-On Offering, Expects to Close on August 5 - AInvest
Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants - GlobeNewswire
Cancer Detection Biotech Mainz Biomed Secures $3.0M Funding to Advance Early Detection Programs - Stock Titan
What is Mainz Biomed N.V. company’s growth strategySuperior portfolio returns - Jammu Links News
Should I hold or sell Mainz Biomed N.V. stock in 2025Achieve rapid capital gains with smart investing - Jammu Links News
Is Mainz Biomed N.V. stock overvalued or undervaluedGet alerts on high-potential market moves - Jammu Links News
What institutional investors are buying Mainz Biomed N.V. stockGet real-time updates on market movers - Jammu Links News
What is the risk reward ratio of investing in Mainz Biomed N.V. stockSkyrocketing returns - Jammu Links News
Why is Mainz Biomed N.V. stock attracting strong analyst attentionBuild wealth steadily with proven investment strategies - Jammu Links News
How does Mainz Biomed N.V. compare to its industry peersGet alerts on the hottest market movers - Jammu Links News
What is the dividend policy of Mainz Biomed N.V. stockRapid return acceleration - Jammu Links News
Does Mainz Biomed N.V. stock perform well during market downturnsTremendous return on equity - Jammu Links News
How strong is Mainz Biomed N.V. company’s balance sheetUnprecedented growth rates - Jammu Links News
What catalysts could drive Mainz Biomed N.V. stock higher in 2025Capitalize on market trends with confidence - Jammu Links News
How many analysts rate Mainz Biomed N.V. as a “Buy”Advanced Screener Planner For 2025 - Jammu Links News
Mainz Biomed Announces Sale of 1.47 Million Ordinary Units to Bolster Financial Position and Support Growth Initiatives - AInvest
What are Mainz Biomed N.V. company’s key revenue driversDaily Trading Outlook With Proven Results - Jammu Links News
Chartists See Breakout Potential in Mainz Biomed N.V.Real Trader Watchlist of Hot Stocks Released - metal.it
Why Mainz Biomed N.V. stock attracts strong analyst attentionROI Boosting Trade Opportunity Calendar Published - metal.it
What are the technical indicators suggesting about Mainz Biomed N.V.Stay ahead with advanced stock screening tools - Jammu Links News
What institutions are buying Mainz Biomed N.V. stock nowFree Stock Market Beginners Guide - metal.it
Mainz Biomed N.V. Stock Analysis and ForecastStrong return on assets - Jammu Links News
Does Mainz Biomed N.V. stock pay reliable dividendsRapid capital growth - Jammu Links News
Should I buy Mainz Biomed N.V. stock before earningsHigh-impact stock picks - Jammu Links News
What drives Mainz Biomed N.V. stock priceUnprecedented market success - Autocar Professional
1.12%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):